Registry of Lobbyists

Health Canada (HC) in Monthly Communication Reports in: June 2022

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Results 1-50 of 121

  • Association des collèges et universités francophones
    Consultant: Yan Plante
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Sous-ministre | Health Canada (HC)

    Subject Matter of the communication: Education, Health
    Communication date: 2022-06-30
    Posted date: 2022-06-30
    Communication number: 372245-536525 View associated registration
  • High Tide Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health
    Communication date: 2022-06-30
    Posted date: 2022-06-30
    Communication number: 370649-536533 View associated registration
  • Canadian Red Cross
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Heather Jeffrey, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Budget
    Communication date: 2022-06-30
    Posted date: 2022-07-15
    Communication number: 16764-537997 View associated registration
  • Dairy Farmers of Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of Minister Duclos | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Health, Agriculture
    Communication date: 2022-06-30
    Posted date: 2022-07-15
    Communication number: 513-538566 View associated registration
  • Baking Association of Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Karen McIntyre, Director General | Health Canada | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-30
    Posted date: 2022-08-09
    Communication number: 465-539368 View associated registration
  • Canadian Association for Long-Term Care
    Consultant: Chris Steer
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health | Health Canada (HC)
    • Julia Duncan, Senior Policy Advisor | Office of Minister of Mental Health & Addictions | Health Canada (HC)
    • Kaitlyn Forbes, Policy Advisor | Office of Minister of Mental Health & Addictions | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-29
    Posted date: 2022-07-15
    Communication number: 370703-536898 View associated registration
  • Canadian Association for Long Term Care
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Carolyn Bennett, Minister of Mental Health and Addictions and Associate Minister of Health | Health Canada (HC)
    • Julia Duncan, Senior Policy Advisor | Office of Minister of Mental Health & Addictions | Health Canada (HC)
    • Kaitlyn Forbes, Policy Advisor | Office of Minister of Mental Health & Addictions | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-29
    Posted date: 2022-07-11
    Communication number: 369728-536899 View associated registration
  • University of Saskatchewan
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Maja Staka, Press Secretary | Health Canada (HC)
    • Eric Belair, Associate Assistant Deputy Minister | Health Canada (HC)
    • Carolyn Bennett, Minister of Health | Prime Minister's Office (PMO)

    Subject Matter of the communication: Education, Health, Immigration, Research and Development
    Communication date: 2022-06-28
    Posted date: 2022-07-15
    Communication number: 5262-538211 (amended from 5262-538197) View associated registration
  • Medsup Canada
    Consultant: Marc Desmarais
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Office of the Minister | Health Canada (HC)
    • Victor Kandasamy, Policy Advisor (Quebec) | Office of the Minister | Health Canada (HC)
    • Marie-France Proulx, Press Secretary | Office of the Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
    Communication date: 2022-06-27
    Posted date: 2022-07-15
    Communication number: 369351-536334 View associated registration
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister | COVID-19 Testing, Contact Tracing and Data Strategy Secretariat | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-27
    Posted date: 2022-07-15
    Communication number: 15042-537070 View associated registration
  • Innovative Medicines Canada
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Federal Lead and Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-27
    Posted date: 2022-07-14
    Communication number: 371-537606 View associated registration
  • Pfizer Canada ULC
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-27
    Posted date: 2022-07-15
    Communication number: 15283-537998 View associated registration
  • Hoffmann-La Roche Limited
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Industry
    Communication date: 2022-06-27
    Posted date: 2022-07-15
    Communication number: 64-538104 View associated registration
  • Greater Toronto Airports Authority
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Karl Sasseville, Deputy Chief of Staff | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-27
    Posted date: 2022-07-15
    Communication number: 14692-538384 View associated registration
  • Bayer Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephan Lucas, Deputy Minister | Health Canada (HC)
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
    Communication date: 2022-06-27
    Posted date: 2022-09-02
    Communication number: 4969-540729 View associated registration
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-24
    Posted date: 2022-06-24
    Communication number: 15270-536285 View associated registration
  • The Canada Life Assurance Company
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Mojoomdar, Director, Specialty Pharmaceuticals | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-24
    Posted date: 2022-07-15
    Communication number: 224181-536400 (amended from 224181-536399) View associated registration
  • Life Sciences Ontario
    Consultant: Stephanie Levee
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Industry, Science and Technology, Economic Development, Intellectual Property, Regional Development, Health, International Trade, Research and Development
    Communication date: 2022-06-24
    Posted date: 2022-07-15
    Communication number: 372173-536723 View associated registration
  • Life Sciences Ontario
    Consultant: WILLIAM DEMPSTER
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Economic Development, Health, Industry, Intellectual Property, International Trade, Regional Development, Research and Development, Science and Technology
    Communication date: 2022-06-24
    Posted date: 2022-07-15
    Communication number: 361060-536726 View associated registration
  • Life Sciences Ontario (LSO)
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • Samir Khan, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Budget, Economic Development, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2022-06-24
    Posted date: 2022-07-15
    Communication number: 368641-536729 View associated registration
  • Merck Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
    • samir khan, Sr Advisor for Employment | Employment and Social Development Canada (ESDC)

    Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
    Communication date: 2022-06-24
    Posted date: 2022-07-12
    Communication number: 12241-537205 View associated registration
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director, Office of Pharmaceuticals Management Strategies | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-24
    Posted date: 2022-07-15
    Communication number: 15042-537377 View associated registration
  • Canadian Canola Growers Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Frederic Bissonnette, Director General - Chief Registrar, PMRA | Health Canada (HC)
    • Manon Bombardier, Assistant Deputy Minister, PMRA Transformation | Health Canada (HC)
    • Margherita Conti, Director General, Value Assessment and Re-Evaluation Management Directorate, PMRA | Health Canada (HC)
    • Jamie Murray , Director General, Environmental Assessment Directorate, PMRA | Health Canada (HC)
    • Jason Flint, Director General, Policy and Operations, PMRA | Health Canada (HC)
    • Jason Proceviat, Director General, Program Renewal, PMRA | Health Canada (HC)

    Subject Matter of the communication: Environment, International Trade, Health, Agriculture
    Communication date: 2022-06-23
    Posted date: 2022-06-23
    Communication number: 17195-536240 View associated registration
  • AccertaClaim Servicorp Inc.
    Consultant: Derrick Araneda
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-23
    Posted date: 2022-06-27
    Communication number: 371818-536319 View associated registration
  • Québec Association of Pharmacy Distributors
    Consultant: Hugues Mousseau
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Conseiller principal, Politiques | Cabinet du ministre | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-23
    Posted date: 2022-06-28
    Communication number: 367162-536373 View associated registration
  • Association québécoise des distributeurs en pharmacie
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Conseiller principal, Politiques | Cabinet du ministre | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-23
    Posted date: 2022-06-28
    Communication number: 366176-536388 View associated registration
  • Greater Toronto Airports Authority
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Harpreet Kochhar, Associate Deputy Minister | Health Canada (HC)
    • Omar Alghabra, Minister of Transport | Transport Canada (TC)
    • Michael Keenan, Deputy Minister | Transport Canada (TC)
    • John Ossowski, President | Canada Border Services Agency (CBSA)
    • Ted Gallivan, Executive Vice-President | Canada Border Services Agency (CBSA)
    • Kathy Thompson, Executive Vice-President | Public Health Agency of Canada (PHAC)
    • Mike Saunders, President and CEO | Canadian Air Transport Security Authority (CATSA)

    Subject Matter of the communication: Transportation
    Communication date: 2022-06-23
    Posted date: 2022-07-15
    Communication number: 14692-538367 View associated registration
  • Innovative Medicines Canada
    Consultant: Andy Singh
    Designated Public Office Holders who participated in the communication:
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-23
    Posted date: 2022-07-15
    Communication number: 371107-538554 View associated registration
  • CANADIAN NURSES ASSOCIATION/ASSOCIATION DES INFIRMIERES ET INFIRMIERS DU CANADA(CNA)
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Joanna Lam, Special Assistant (Regional Advisor - Western and Northern Canada) | Minister's Office | Health Canada (HC)
    • Jordan Ames-Sinclair, Policy Assistant | Health Canada (HC)

    Subject Matter of the communication: Health, Budget, Federal-Provincial Relations
    Communication date: 2022-06-22
    Posted date: 2022-07-15
    Communication number: 75-536191 View associated registration
  • Canadian Generic Pharmaceutical Association (CGPA)
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-22
    Posted date: 2022-07-15
    Communication number: 548-536335 View associated registration
  • The Centre for Israel and Jewish Affairs
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Hershaw, Director of Operations | Health Canada (HC)

    Subject Matter of the communication: Religion, Agriculture
    Communication date: 2022-06-22
    Posted date: 2022-07-15
    Communication number: 111-537178 View associated registration
  • CANADIAN CONSUMER SPECIALTY PRODUCTS ASSOCIATION
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-22
    Posted date: 2022-07-12
    Communication number: 319-537234 View associated registration
  • Groupe Marcelle Cosmetics
    Consultant: Susie Heath
    Designated Public Office Holders who participated in the communication:
    • Joanna Lam, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Consumer Issues, Economic Development, Environment, Health
    Communication date: 2022-06-22
    Posted date: 2022-07-15
    Communication number: 372200-538071 View associated registration
  • University of Calgary
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Hillary Morgan, Policy Advisor | Office of the Minister of Mental Health and Addictions | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-22
    Posted date: 2022-07-15
    Communication number: 5009-538295 View associated registration
  • Pharmascience Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-21
    Posted date: 2022-06-22
    Communication number: 234102-536144 View associated registration
  • AbbVie Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry
    Communication date: 2022-06-21
    Posted date: 2022-06-24
    Communication number: 15270-536284 View associated registration
  • Life Sciences Ontario
    Consultant: Stephanie Levee
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Industry, Science and Technology, Economic Development, Intellectual Property, Regional Development, Health, International Trade, Research and Development
    Communication date: 2022-06-21
    Posted date: 2022-07-15
    Communication number: 372173-536620 View associated registration
  • Life Sciences Ontario (LSO)
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Budget, Economic Development, Health, Industry, Intellectual Property, International Trade, Research and Development, Science and Technology, Taxation and Finance
    Communication date: 2022-06-21
    Posted date: 2022-07-15
    Communication number: 368641-536728 View associated registration
  • Merck Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
    Communication date: 2022-06-21
    Posted date: 2022-07-12
    Communication number: 12241-537203 View associated registration
  • HealthCareCAN
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Susan Weston, Manager | Health Care Programs and Policy Directorate | Health Canada (HC)
    • Jocelyne Voisin, Assistant Deputy Minister | Health Canada (HC)
    • Sharon Harper, Director, Policy | Strategic Policy Branch | Health Canada (HC)
    • Brennan Graham, Policy Advisor | Assitant Deputy Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health, Labour, Employment and Training
    Communication date: 2022-06-21
    Posted date: 2022-07-13
    Communication number: 16722-537246 View associated registration
  • AstraZeneca Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-21
    Posted date: 2022-07-15
    Communication number: 15042-537715 View associated registration
  • Canadian Mental Health Association
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Shaili Patel, Director of Policy | Minister for Mental Health and Addiction | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-21
    Posted date: 2022-07-15
    Communication number: 15788-538065 View associated registration
  • Green Shield Canada
    Consultant: Richard Mahoney
    Designated Public Office Holders who participated in the communication:
    • Sarah Welch, Chief of Staff | Office of the Minister of Mental Health and Addictions | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-21
    Posted date: 2022-07-15
    Communication number: 372016-538152 View associated registration
  • TELUS Corporation
    Consultant: Michelle McLean
    Designated Public Office Holders who participated in the communication:
    • Hillary Morgan, Senior Policy Advisor | Office of the Minister of Mental Health and Addictions and Associate Minister of Health | Health Canada (HC)
    • Kaitlyn Forbes, Policy Advisor | Office of the Minister of Mental Health and Addictions and Associate Minister of Health | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-21
    Posted date: 2022-08-09
    Communication number: 366226-539393 View associated registration
  • Canadian Federation of Humane Societies (also known as Humane Canada)
    In-house Organization
    Designated Public Office Holders who participated in the communication:
    • Paul Hershaw, Director of Operations | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Animal Welfare
    Communication date: 2022-06-20
    Posted date: 2022-06-22
    Communication number: 6433-536063 View associated registration
  • Merck Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)
    • Supriya Sharma, Chief Medical Advisor | Health Canada (HC)

    Subject Matter of the communication: Health, Industry, Research and Development, Science and Technology
    Communication date: 2022-06-20
    Posted date: 2022-07-12
    Communication number: 12241-537201 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-17
    Posted date: 2022-06-27
    Communication number: 5088-536301 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Michelle Boudreau , Executive Director | Strategic Policy Branch | Health Canada (HC)

    Subject Matter of the communication: Health
    Communication date: 2022-06-17
    Posted date: 2022-06-30
    Communication number: 5088-536504 View associated registration
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Stephen Lucas, Sous-ministre | Health Products and food branch | Health Canada (HC)
    • Nancy Hamzawi, Assistant Deputy Minister | Health Canada (HC)

    Subject Matter of the communication: Industry, Intellectual Property, Science and Technology, Health, International Trade
    Communication date: 2022-06-17
    Posted date: 2022-07-04
    Communication number: 15599-536615 View associated registration
  • Moderna Biopharma Canada Corporation
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jean-Yves Duclos, Minister of Health | Health Canada (HC)
    • Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
    • Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)

    Subject Matter of the communication: Government Procurement, Health, Research and Development, Science and Technology
    Communication date: 2022-06-17
    Posted date: 2022-07-11
    Communication number: 370107-537041 View associated registration
Return to Government Institutions in Monthly Communication Reports
Date Modified: